Tag Archives: Mel Spigelman

Public and Private Sector Partners Help to Jump Start Development of New TB Drug Combinations

By on .

This post is by Global Center Director Christine Lubinski. The excitement in the room was palatable today as FDA Commissioner Margaret Hamburg joined representatives from the Global Alliance for TB Drug Development, the Bill & Melinda Gates Foundation, the Treatment Action Campaign, and representatives from the pharmaceutical industry to announce a new collaboration to accelerate […]

Promising New TB Drugs Put on a Fast Track

By on .

This afternoon, Dr. Mel Spigelman, president and CEO of the Global Alliance for TB Drug Development, and other leading TB advocates will join with FDA Commissioner Margaret Hamburg to launch a new initiative designed to accelerate the development and approval of life-saving new treatments for tuberculosis. There are now at least 9 promising new TB […]

Aren’t These Lives Worth Saving, Too?

By on .

This is a guest blog jointly submitted by Jerald C. Sadoff, MD, the President & Chief Executive Officer of the Aeras Global TB Vaccine Foundation and Mel Spigelman, MD, the President & Chief Executive Officer of the Global Alliance for TB Drug Development. In recent weeks, U.S.-based global health advocates have been scrutinizing and providing […]